+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum medians for placental proteins in pregnancies achieved by IVF are different from those of spontaneous pregnancies Implications for fetal trisomy screening



Serum medians for placental proteins in pregnancies achieved by IVF are different from those of spontaneous pregnancies Implications for fetal trisomy screening



Human Reproduction 15(Abstract Book 1): 171




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035719026

Download citation: RISBibTeXText


Related references

Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21. Fetal Diagnosis & Therapy 13(5): 291-297, 1998

Maternal Serum Placental Growth Hormone and Insulinlike Growth Factor Binding Proteins 1 and 3 in Pregnancies Affected by Fetal Aneuploidy and Other Abnormalities: Implications for Prenatal Diagnosis of Trisomy 21. Fetal Diagnosis and Therapy 13(5): 291-297, 1998

Maternal serum beta-hCG levels in screening for Down syndrome are higher in singleton pregnancies achieved with ovulation induction and intrauterine insemination than in spontaneous singleton pregnancies. Fertility and Sterility 76(5): 1075-1077, 2001

A meiotic origin of the trisomy in pregnancies with confined placental mosaicism is correlated with increased risk of fetal IUGR, UPD, and high levels of trisomy in placental trophoblast. American Journal of Human Genetics 59(4 Suppl. ): A41, 1996

First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Human Reproduction 16(7): 1501-1504, 2001

Maternal serum human placental growth hormone at 11 to 13 weeks in trisomy 21 and trisomy 18 pregnancies. Prenatal Diagnosis 30(3): 212-215, 2010

First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18. Prenatal Diagnosis 21(9): 718-722, 2001

Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. American Journal of Obstetrics and Gynecology 200(1): 98.E1, 2009

First trimester maternal serum placental growth factor in trisomy 21 pregnancies. Prenatal Diagnosis 30(5): 449-453, 2010

Maternal serum placental growth factor in second trimester trisomy 21 pregnancies. Prenatal Diagnosis 32(2): 117-121, 2012

Spontaneous pregnancies and pregnancies as a result of treatment on an in vitro fertilization program terminating in ectopic pregnancies or spontaneous abortions. Fertility and Sterility 50(1): 85-88, 1988

Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. Prenatal Diagnosis 30(3): 229-234, 2010

Early first-trimester maternal serum placental growth factor in trisomy 21 pregnancies. Ultrasound in Obstetrics and Gynecology 37(5): 515-519, 2011

Maternal serum markers in pregnancies associated with fetal trisomy 21 of native Japanese women with or without fetal morphological abnormalities. Hokkaido Journal of Medical Science 78(2): 139-145, 2003

Of pregnancies complicated by small for gestational age babies at term, what proportions have placental findings with implications for future pregnancies or neonatal outcomes?. Journal of Maternal-Fetal and Neonatal Medicine 2019: 1-6, 2019